ClinicalTrials.gg
CompletedNCT07834060Updated Sep 22, 2026

Perioperative QT and QTc Changes in Laparoscopic and Open Hysterectomy

An observational study in QT Interval and Hysterectomy, sponsored by Haseki Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Haseki Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
18 Years and older
Sex
Female
01

Study summary

This prospective observational study evaluated perioperative changes in QT and corrected QT (QTc) intervals in adult women undergoing elective laparoscopic or open abdominal hysterectomy under general anesthesia. The surgical approach was determined by the treating gynecologic surgeon according to routine clinical considerations and was not assigned by the investigators. All patients received a standardized general anesthesia and monitoring protocol. QT and QTc intervals were recorded at predefined perioperative time points from before anesthesia induction to immediately after tracheal extubation. The study aimed to compare the magnitude and pattern of perioperative QT and QTc changes between laparoscopic and open abdominal hysterectomy and to evaluate associated perioperative hemodynamic and respiratory adverse events.

Read the detailed description

This was a prospective, single-center observational cohort study including 48 adult female patients with American Society of Anesthesiologists physical status I-II undergoing elective hysterectomy under general anesthesia. Patients were classified into two cohorts according to the surgical approach: laparoscopic hysterectomy (Group L) and open abdominal hysterectomy (Group A). The surgical technique was selected independently by the treating gynecologic surgeon based on clinical considerations and was not determined by the study investigators.

A standardized general anesthesia protocol was applied to both groups. Continuous electrocardiographic monitoring was performed, and QT intervals were automatically measured from lead II using the perioperative monitoring system. Corrected QT intervals were calculated automatically using Bazett's formula.

QT and QTc intervals were evaluated at predefined perioperative time points: before anesthesia induction (T0), after anesthesia induction (T1), immediately before tracheal intubation (T2), immediately after tracheal intubation (T3), before the relevant surgical stimulus (T4), immediately after the surgical stimulus (T5), at the end of surgery (T6), and immediately after tracheal extubation (T7). In addition, the difference between the maximum and minimum perioperative QT and QTc values obtained from measurements recorded at five-minute intervals was evaluated. Hemodynamic and respiratory adverse events were also recorded.

02

Conditions studied

  • QT Interval
  • Hysterectomy

Browse trials for

Keywords

  • QT interval
  • QTc interval
  • cardiac repolarization
  • laparoscopic hysterectomy
  • abdominal hysterectomy
  • pneumoperitoneum
  • general anesthesia
  • electrocardiography
03

In context

Pneumoperitoneum

134 studies on the registry are indexed under Pneumoperitoneum; 28 are open to participants now.

This study's enrollment of 48 is below the median of 59 across 48 observational studies indexed under Pneumoperitoneum.

Browse Pneumoperitoneum studies →

Lead sponsor

Haseki Training and Research Hospital is the lead sponsor of 78 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult female patients with ASA physical status I-II undergoing elective laparoscopic or open abdominal hysterectomy under general anesthesia at Sultangazi Haseki Training and Research Hospital, Istanbul, Türkiye.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients scheduled for elective laparoscopic or open abdominal hysterectomy under general anesthesia
  • physical status I-II
  • Written for participation

Exclusion criteria

Exclusion Criteria:

  • Unstable angina
  • Severe heart failure
  • Preoperative >460 ms
  • Use of medications known to affect the QTc interval
  • Family history of long QT syndrome
  • Cardiac arrhythmia or conduction abnormality on electrocardiography
  • Permanent pacemaker
  • Electrolyte abnormalities
  • Hepatic disease
  • Renal disease
  • Anemia
  • Neuromuscular disease
  • Refusal to participate
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

QT and QTc

On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.

The study may name a correction formula and a limit in milliseconds, often around 450–480.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (actual)
Patient registry
No

Groups and cohorts

  • Group L - laparoscopic hysterectomy

    Adult female patients undergoing elective laparoscopic hysterectomy under general anesthesia. The laparoscopic surgical approach was selected by the treating gynecologic surgeon as part of routine clinical care and was not assigned by the investigators.

    Procedure: Laparoscopic hysterectomy

  • Group A - abdominal abdominal hysterectomy

    Adult female patients undergoing elective open abdominal hysterectomy under general anesthesia. The open surgical approach was selected by the treating gynecologic surgeon as part of routine clinical care and was not assigned by the investigators.

    Procedure: Open Abdominal Hysterectomy

Interventions

  • ProcedureLaparoscopic hysterectomy

    Adult female patients undergoing elective laparoscopic hysterectomy under general anesthesia. The laparoscopic surgical approach was selected by the treating gynecologic surgeon as part of routine clinical care and was not assigned by the investigators.

  • ProcedureOpen Abdominal Hysterectomy

    Adult female patients undergoing elective open abdominal hysterectomy under general anesthesia. The open surgical approach was selected by the treating gynecologic surgeon as part of routine clinical care and was not assigned by the investigators.

06

What researchers measure

Primary outcomes

  1. Perioperative Change in QT Interval

    QT interval, expressed in milliseconds (ms), was automatically measured from lead II of the electrocardiogram. QT intervals were assessed at eight predefined perioperative time points (T0-T7) and compared according to time, surgical group, and group × time interaction.

    Time frame: From before induction of general anesthesia to immediately after tracheal extubation on the day of surgery.

  2. Perioperative Change in Corrected QT (QTc) Interval

    Corrected QT (QTc) interval, expressed in milliseconds (ms), was automatically calculated using Bazett's formula (QTc = QT/√RR). QTc intervals were assessed at eight predefined perioperative time points (T0-T7) and compared according to time, surgical group, and group × time interaction.

    Time frame: From before induction of general anesthesia to immediately after tracheal extubation on the day of surgery.

Secondary outcomes

  1. Maximum Perioperative Change in QT Interval (ΔQT)

    Difference, expressed in milliseconds, between the maximum and minimum QT intervals recorded during perioperative measurements obtained at five-minute intervals.

    Time frame: From before induction of anesthesia to immediately after extubation on the day of surgery.

  2. Maximum Perioperative Change in QTc Interval (ΔQTc)

    Difference, expressed in milliseconds, between the maximum and minimum QTc intervals recorded during perioperative measurements obtained at five-minute intervals.

    Time frame: From before induction of anesthesia to immediately after extubation on the day of surgery.

  3. Incidence of Hypotension

    Number and percentage of participants who developed intraoperative hypotension, defined as mean arterial pressure ≤70 mmHg.

    Time frame: From before induction of anesthesia to immediately after extubation on the day of surgery.

  4. Incidence of bradycardia

    Number and percentage of participants who developed intraoperative bradycardia, defined as heart rate \<60 bpm.

    Time frame: From before induction of anesthesia to immediately after extubation on the day of surgery.

07

Study locations

1 site
  • Sultangazi Haseki Training and Research Hospital
    Istanbul, Istanbul 34265, Turkey (Türkiye)
08

References and documents

Publications

  • Stamate E, Piraianu AI, Duca OM, Ciobotaru OR, Fulga A, Fulga I, Onisor C, Matei MN, Luchian AS, Dumitrascu AG, Ciobotaru OC. The Effect of Increased Intra-Abdominal Pressure on Hemodynamics in Laparoscopic Cholecystectomy-The Experience of a Single Centre. J Pers Med. 2024 Aug 17;14(8):871. doi: 10.3390/jpm14080871. PubMed 39202062 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared because data sharing was not included in the study's approved protocol and participant consent, and no data-sharing arrangements have been established.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2023 to primary completion in Jan 2024, 3 months.

Of 26 observational studies under Pneumoperitoneum, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 17. This study's 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2026
First posted
Sep 22, 2026
StartActual
Oct 15, 2023
Primary completionActual
Jan 15, 2024
CompletionActual
Jan 15, 2024
Last update
Sep 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07834060
Lead sponsor
Haseki Training and Research Hospital
Responsible party
Sinan Uzman (Associate prof., Haseki Training and Research Hospital) — Principal investigator
First posted
Sep 22, 2026
Start date
Oct 15, 2023
Primary completion
Jan 15, 2024
Completion
Jan 15, 2024
Last update
Sep 22, 2026

Study contacts

Sinan Uzman, Assoc. prof.
study director · Sultangazi Haseki Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion